• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉维霉素(AY - 25,545),一种新型抗肿瘤抗生素。

Ravidomycin (AY-25,545), a new antitumor antibiotic.

作者信息

Sehgal S N, Czerkawski H, Kudelski A, Pandev K, Saucier R, Vézina C

出版信息

J Antibiot (Tokyo). 1983 Apr;36(4):355-61. doi: 10.7164/antibiotics.36.355.

DOI:10.7164/antibiotics.36.355
PMID:6853365
Abstract

A streptomycete was isolated from a Guatemala soil sample and found to inhibit Grampositive bacteria including mycobacteria. The antibiotic-producing microorganism was characterized, identified as a new species and named Streptomyces ravidus. The antibiotic principle was extracted with organic solvent from the mycelium, isolated in crystalline form and named ravidomycin. Ravidomycin is mainly active against Gram-positive bacteria including mycobacteria. It shows only weak activity against Gram-negative organisms and no activity against fungi. Ravidomycin exhibits potent antitumor activity against P388 lymphocytic leukemia, Colon 38 tumor and CD8F1 mammary tumor. Acute toxicity in mice is low.

摘要

从危地马拉土壤样本中分离出一种链霉菌,发现它能抑制包括分枝杆菌在内的革兰氏阳性菌。对这种产生抗生素的微生物进行了表征,鉴定为一个新物种,并命名为嗜热链霉菌。抗生素成分用有机溶剂从菌丝体中提取出来,以结晶形式分离出来,命名为嗜热霉素。嗜热霉素主要对包括分枝杆菌在内的革兰氏阳性菌有活性。它对革兰氏阴性菌只有微弱活性,对真菌无活性。嗜热霉素对P388淋巴细胞白血病、结肠38肿瘤和CD8F1乳腺肿瘤具有强大的抗肿瘤活性。对小鼠的急性毒性较低。

相似文献

1
Ravidomycin (AY-25,545), a new antitumor antibiotic.拉维霉素(AY - 25,545),一种新型抗肿瘤抗生素。
J Antibiot (Tokyo). 1983 Apr;36(4):355-61. doi: 10.7164/antibiotics.36.355.
2
Deacetylravidomycin N-oxide, a new antibiotic. Taxonomy and fermentation of the producing organism and isolation, structure and biological properties of the antibiotic.去乙酰拉维多霉素N-氧化物,一种新型抗生素。产生该抗生素的生物体的分类学、发酵以及该抗生素的分离、结构和生物学特性。
J Antibiot (Tokyo). 1989 Mar;42(3):347-56. doi: 10.7164/antibiotics.42.347.
3
A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity.
J Antibiot (Tokyo). 1988 Nov;41(11):1575-9. doi: 10.7164/antibiotics.41.1575.
4
Prothracarcin, a novel antitumor antibiotic.原癌菌素,一种新型抗肿瘤抗生素。
J Antibiot (Tokyo). 1982 Aug;35(8):972-8. doi: 10.7164/antibiotics.35.972.
5
Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.雷帕霉素(AY - 22,989),一种新型抗真菌抗生素。I. 产生该抗生素的链霉菌的分类及活性成分的分离
J Antibiot (Tokyo). 1975 Oct;28(10):721-6. doi: 10.7164/antibiotics.28.721.
6
LL-D49194 antibiotics, a novel family of antitumor agents: taxonomy, fermentation and biological properties.LL-D49194抗生素,一类新型抗肿瘤药物:分类学、发酵及生物学特性
J Antibiot (Tokyo). 1990 Mar;43(3):253-8. doi: 10.7164/antibiotics.43.253.
7
A new antitumor substance, BE-18591, produced by a streptomycete. I. Fermentation, isolation, physico-chemical and biological properties.一种由链霉菌产生的新型抗肿瘤物质BE-18591。I. 发酵、分离、理化性质及生物学特性
J Antibiot (Tokyo). 1993 Dec;46(12):1799-803. doi: 10.7164/antibiotics.46.1799.
8
Chicamycin, a new antitumor antibiotic. I. Production, isolation and properties.
J Antibiot (Tokyo). 1984 Mar;37(3):191-9. doi: 10.7164/antibiotics.37.191.
9
Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. I. Taxonomy of producing organism, fermentation and biological activity.喜他汀,一种来自吸水链霉菌的新型抗肿瘤抗生素。I. 产生菌的分类学、发酵及生物活性
J Antibiot (Tokyo). 1990 Aug;43(8):956-60. doi: 10.7164/antibiotics.43.956.
10
Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities.吉尔vocarcins,新型抗肿瘤抗生素。1. 分类学、发酵、分离及生物活性。
J Antibiot (Tokyo). 1981 Mar;34(3):266-70. doi: 10.7164/antibiotics.34.266.

引用本文的文献

1
Ravidomycin Analogs from sp. Exhibit Altered Antimicrobial and Cytotoxic Selectivity.**从** sp.中分离得到的瑞达霉素类似物表现出改变的抗微生物和细胞毒性选择性。
J Nat Prod. 2023 Aug 25;86(8):1968-1979. doi: 10.1021/acs.jnatprod.3c00381. Epub 2023 Aug 2.
2
Bioactive Natural Products in Actinobacteria Isolated in Rainwater From Storm Clouds Transported by Western Winds in Spain.西班牙西风携带的暴雨云雨水样中分离出的放线菌产生的生物活性天然产物
Front Microbiol. 2021 Nov 10;12:773095. doi: 10.3389/fmicb.2021.773095. eCollection 2021.
3
Delineation of gilvocarcin, jadomycin, and landomycin pathways through combinatorial biosynthetic enzymology.
通过组合生物合成酶学描绘吉尔沃卡林、氮霉素和土地霉素途径。
Curr Opin Chem Biol. 2012 Apr;16(1-2):150-61. doi: 10.1016/j.cbpa.2012.03.007. Epub 2012 Mar 30.
4
Enzymatic total synthesis of defucogilvocarcin M and its implications for gilvocarcin biosynthesis.去甲吉尔vocarcin M的酶促全合成及其对吉尔vocarcin生物合成的意义。
Angew Chem Int Ed Engl. 2012 Jan 27;51(5):1216-20. doi: 10.1002/anie.201105882. Epub 2011 Dec 23.
5
Engineered biosynthesis of gilvocarcin analogues with altered deoxyhexopyranose moieties.工程化生物合成具有改变的脱氧己糖部分的吉尔沃卡林类似物。
Appl Environ Microbiol. 2011 Jan;77(2):435-41. doi: 10.1128/AEM.01774-10. Epub 2010 Nov 12.
6
Cloning and characterization of the ravidomycin and chrysomycin biosynthetic gene clusters.裂霉素和金霉素生物合成基因簇的克隆与特性分析。
Chembiochem. 2010 Mar 1;11(4):523-32. doi: 10.1002/cbic.200900673.